Abstract
Methadone maintenance therapy has, as main objective, the reducing of heroin craving, managing poly-drug use to achieve a total abstinence. The objective is to evaluate the relapse and poly-drug use after inclusion in Methadone treatment.
The results showed that the poly-drug use was significantly reduced after treatment concerning alcohol, cocaine and heroin, however, the consumption of tobacco and cannabis did not have a significant change. The rest of the substances had almost the same frequency. Relapse was assessed with (62%) of heroine intakes. Subjects with heroin-only or poly-drug use problems have a higher percentage of overdoses than others with (47%). The relapse and number of heroine uses is correlated with degree of the satisfaction toward the treatment.
Poly-drug use is a primary problem should be a subject of in-depth research and main management to optimize the control of long-term dependence
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Government Accountability Office.
References
Guignard, R., Beck, F., Obradovic, I.: Prise en charge des addictions par les médecins généralistes. In: Gautier, A. (ed.) Baromètre santé médecins généralistes 2009. Inpes, coll., pp. 177–201. Baromètres santé, Saint-Denis (2011)
Manoudi, F., Boutabia, S., Asri, F., Tazi, I.: Approche épidémiologique de la toxicomanie en milieu universitaire à Marrakech (Maroc). Annales Médico-psychologiques, revue psychiatrique 168(9), 698–701 (2010). https://doi.org/10.1016/j.amp.2010.09.003
Alarming figures on the number of drug addicts and drug addicts in Morocco [Internet]. Le Site Info. https://www.lesiteinfo.com/maroc/chiffres-alarmants-nombre-de-drogues-toxicomanes-maroc/
Caldéron, C., Guichard, A., Maguet, O., Lert, F.: Du point de vue des usagers, quels sont les effets, les bénéfices et les difficultés suscités par les traitements de substitution aux opiacés?. Alcoologie Et Addictologie 26(45), 615–745 (2004). https://www.semanticscholar.org/paper/Du-point-de-vue-des-usagers%2C-quels-sont-les-effets%2C-Guichard-Calderon/4e06b2a02192a2cee2d5c9035239c04a14b25193
Mattick, R., Breen, C., Kimber, J., Davoli, M.: Methadone maintenance therapy versus no opioid replacement therapy for opioid dependenceCochrane Database Syst. Rev.https://doi.org/10.1002/14651858.cd002209.pub2
Cousineau, D., Gariépy, M.: Les drogues de substitution, 4th edn. Comité permanent de lutte à la toxicomanie (2000)
Monassier, L.: LES ANALGESIQUES CENTRAUX OPIACES. Dans Module de Pharmacologie Clinique DCEM3 2005/2006. Faculté de Médecine de Strasbourg, Strasbourg, pp. 1–11 (2005)
Gaudillière, B.: Les Représentations De La Méthadone Et De La Buprénorphine Haut Dosage Chez Les Patients Toxicomanes [Thèse]. Université Pierre Et Marie Curie (Paris 6) Faculté De Médecine Pierre Et Marie Curie (2007). http://www.cmgeupmc.org/IMG/pdf/gaudilliere_these_toxico.pdf
Karila, L., Coscas, S., Lecacheux, M., Noble, F., Legleye, S., Beck, F., et al.: Conduites addictives. EMC - Traité de médecine AKOS 3(1), 1–12 (2008). https://doi.org/10.1016/s1634-6939(08)48039-0
Laqueille, X.: La pratique clinique des traitements de substitution à l’héroïne et les alternatives (2016). http://www.academie-medecine.fr/wpcontent/uploads/2017/06/P.807-818.pdf
Mallaret, M.: Aspects pharmacologiques des produits de substitution de l’héroïne. Dépen dances 7(2), 8, 12. https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=35296
Stotts, A.L., Dodrill, C.L., Kosten, T.R.: Expert Opin Pharmacother. Author manuscript; available in PMC 2010 Aug 1. Published in final edited form as: Expert Opin. Pharmacother. 10(11), 1727–1740 (2009). https://doi.org/10.1517/14656560903037168
Hendriks, V.: The addiction severity index: reliability and validity in a Dutch addict population. J. Subst. Abuse Treat. 6(2), 133–141 (1989). https://doi.org/10.1016/0740-5472(89)90041-x
Mclellan, A., Luborsky, L., Woody, G., O’Brien, C.: An improved diagnostic evaluation instrument for substance abuse patients. J. Nerv. Ment. Dis. 168(1), 26–33 (1980). https://doi.org/10.1097/00005053-198001000-00006
Ball, J., Ross, A.: The Effectiveness of Methadone Maintenance Treatment. Springer, New York (1991)
General Accounting Office: Methadone Maintenance-Some treatment Programs Ar Not Effective; Creator federal Oversight Needed. GAO/HRD-90-104, Washington, DC: Supt. of Docs U.S. Govt. Print. Off. (1990)
Kosten, T., Kleber, H., Morgan, C.: Treatment of cocaine abuse with buprenorphine. Biol. Psychiat. 26(6), 637–639 (1989). https://doi.org/10.1016/0006-3223(89)90090-5
Kolar, A., Brown, B., Weddington, W., Ball, J.: A treatment crisis: cocaine use by clients in methadone maintenance programs. J. Subst. Abuse Treat. 7(2), 101–107 (1990). https://doi.org/10.1016/0740-5472(90)90005-b
DuPont, R.: Marijuana and benzodiazepines in patients receiving methadone treatment. JAMA: J. Am. Med. Assoc. 261(23), 3409 (1989). https://doi.org/10.1001/jama.1989.03420230061018
Calderon, C., Soletti, J., Gaigi, H.: Attentes des usagers de drogues concernant les traitements de substitution: expérience, satisfaction, effets recherchés, effets redoutés. AIDES (2002)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this paper
Cite this paper
Semlali, W.I., Ghailan, T., Karjouh, K., Ahami, A.O.T. (2021). Assessment of Relapse and Poly-Drug Use Among Heroin Addicts Patients Treated with the Methadone. In: Kalra, J., Lightner, N.J., Taiar, R. (eds) Advances in Human Factors and Ergonomics in Healthcare and Medical Devices. AHFE 2021. Lecture Notes in Networks and Systems, vol 263. Springer, Cham. https://doi.org/10.1007/978-3-030-80744-3_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-80744-3_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-80743-6
Online ISBN: 978-3-030-80744-3
eBook Packages: EngineeringEngineering (R0)